Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study (Q24813384)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

9

object named as

Hanno Ulmer

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

author name string

Stefan Jochberger

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Viktoria Mayr

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Günter Luckner

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Dietmar R Fries

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Andreas J Mayr

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Barbara E Friesenecker

6

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Ingo Lorenz

7

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Walter R Hasibeder

8

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Wolfgang Schobersberger

10

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Martin W Dünser

11

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

9 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

R541-8

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Other supportive therapies in sepsis: an evidence-based review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Economics of unfractionated heparin: beyond acquisition cost

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Heparin overview and issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Venous thromboembolism prophylaxis in the medically ill patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Heparin and low molecular weight heparin: background and pharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Venous thromboembolism and its prevention in critical care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Deep vein thrombosis and its prevention in critically ill adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Prospective randomized study comparing the effectiveness and tolerance of various low-molecular-weight heparins in high risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Comparative pharmacokinetics of LMWHs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Pharmacokinetics and pharmacodynamics in the critically ill patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Deep Venous Thrombosis in the Surgical Intensive Care Unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Multiple-organ failure. Generalized autodestructive inflammation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 September 2017

Pharmacokinetics of drugs used in critically ill adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

30 May 2018

Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

30 May 2018

The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

30 May 2018

Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

30 May 2018

Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Logistic regression analysis of potential prognostic factors for pulmonary thromboembolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1297619

28 November 2018

Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either logiparin® (LMWH) or unfractionated heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16277716

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24813384&oldid=2245302101"